New bis ([1, 2, 4] triazolo)[4, 3-a: 3′, 4′-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer …

MM Alanazi, HA Mahdy, NA Alsaif, AJ Obaidullah… - Bioorganic …, 2021 - Elsevier
A new series of bis ([1, 2, 4] triazolo)[4, 3-a: 3′, 4′-c] quinoxaline derivatives were
designed and synthesized to have the main essential pharmacophoric features of VEGFR-2 …
被引用次数：72 相关文章

New bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer …

MM Alanazi, HA Mahdy, NA Alsaif… - Bioorganic …, 2021 - europepmc.org
A new series of bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives were designed
and synthesized to have the main essential pharmacophoric features of VEGFR-2 inhibitors …

New bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer …

MM Alanazi, HA Mahdy, NA Alsaif… - Bioorganic …, 2021 - pubmed.ncbi.nlm.nih.gov
A new series of bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives were designed
and synthesized to have the main essential pharmacophoric features of VEGFR-2 inhibitors …